---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-043683"
form_type: "8-K"
ticker: "SANA"
cik: "0001770121"
company_name: "Sana Biotechnology, Inc."
filed_at: "2023-08-21T23:59:59+00:00"
generated_at: "2026-06-11T06:21:38.055391+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sana Biotechnology terminates Fremont lease for $3.42M; moves manufacturing to Bothell, WA

## Summary
- Lease for 163,193 sq ft in Fremont, CA terminated Aug 30, 2023.
- Termination fee of approximately $3.42 million paid to landlord.
- Irrevocable letter of credit returned; mutual release of claims with customary exclusions.
- Company will establish its planned manufacturing facility at Bothell Facility (79,565 sq ft) instead.

## SEC filing metadata
- accession: 0000950170-23-043683
- form_type: 8-K
- ticker: SANA
- cik: 0001770121
- company_name: Sana Biotechnology, Inc.
- filed_at: 2023-08-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1770121/000095017023043683/0000950170-23-043683-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1770121/000095017023043683/sana-20230817.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-043683
- JSON: https://secwatch.observer/filing/0000950170-23-043683.json
- Plain text: https://secwatch.observer/filing/0000950170-23-043683.txt

## Key facts
- Material Agreements
  Sana Biotechnology, Inc. terminated Lease Agreement with Pacific Commons Owner, LP valued at termination fee of approximately $3.42 million (effective 2023-08-30).
  - Action: termination
  - Agreement: lease
  - Counterparty: Pacific Commons Owner, LP
  - Value: termination fee of approximately $3.42 million
  - Effective: 2023-08-30
  source text: On August 17, 2023, Sana Biotechnology, Inc. (the “ Company ”) entered into a Lease Termination Agreement (the “ Termination Agreement ”) with Pacific Commons Owner, LP (the “ Landlord ”) for the early termination of that certain Lease Agreement between the Company and the Landlord dated July 13, 2021 (the “ Lease ”), pursuant to which the Company leased 163,193 square feet of industrial space located at 5567 Cushing Parkway in Fremont, California (the “ Fremont Premises ”). Under the Termination Agreement, the Lease will terminate on August 30, 2023, and the Company will surrender its rights to the Fremont Premises on or before such date. The Company will pay the Landlord a termination fee of approximately $3.42 million, and the Landlord will return to the Company the irrevocable letter of credit provided by the Company as security under the Lease.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1770121/000095017023043683/0000950170-23-043683-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.